Furthermore, a significantly higher or lower incidence of p53 gene mutations has been found in the Polish (Szymanowska et al., 2006) or a Norwegian population (Lind et al., 2007), respectively, among lung cancer carriers of the Pro allele. The gene discussed is TP53; the disease is lung carcinoma.